IPSC
Century Therapeutics, Inc.Healthcare · $176M market cap
Verdict
We can't put a fair value on IPSC right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.
Business quality
0 of 5 clear the 10% bar. What are the Big Five?
Follow IPSC
Track it on your watchlist and see the full analysis. Free.
Create a free accountInsider activity
Since Sep 4, 2026: no open-market purchases, 2 sales worth $2K and 2 other filings (stock awards, tax withholding and similar). Why purchases matter
Sales
Carr Douglas
SVP Finance & Operations · 2026-09-08
Sold
$521
Russotti Gregory
See Remarks · 2026-09-08
Sold
$1K
Other filings
About Century Therapeutics, Inc.
Century Therapeutics, Inc. is a biotechnology company dedicated to pioneering allogeneic cell therapies for a range of cancers, specifically solid tumors and hematological malignancies. The firm's foremost clinical program is CNTY-101, an allogeneic, induced pluripotent stem cell (iPSC)-derived CAR-iNK cell therapy. This therapy is specifically designed to target CD19 in patients with B-cell lymphoma that has…
Biotechnology
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works